SoftOx Solutions AS

SoftOx Solutions AS Liabilities

The The Liabilities of SoftOx Solutions AS (SOFTX.OL) as of Oct 31, 2026 is 10.98 M NOK. In the previous year, The Liabilities was 25.96 M NOK — a change of -57.71% (lower).

Liabilities

10.98 MNOK

YoY

-57.71%

Last updated:

In 2025, SoftOx Solutions AS's total liabilities amounted to 10.98 M NOK, a -57.71% difference from the 25.96 M NOK total liabilities in the previous year.

The SoftOx Solutions AS Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
8.98 M NOK
Jan 1, 2019
18.50 M NOK
Jan 1, 2020
11.09 M NOK
Jan 1, 2021
18.33 M NOK
Jan 1, 2022
61.83 M NOK
Jan 1, 2023
94.87 M NOK
Jan 1, 2024
25.96 M NOK
Jan 1, 2025
10.98 M NOK
The SoftOx Solutions AS Liabilities history
YEARLiabilitiesYoY
10.98 MNOK-57.71%
25.96 MNOK-72.64%
94.87 MNOK+53.45%
61.83 MNOK+237.34%
18.33 MNOK+65.23%
11.09 MNOK-40.03%
18.50 MNOK+105.86%
8.98 MNOK+114.38%
4.19 MNOK-34.30%
6.38 MNOK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SoftOx Solutions AS Stock analysis

What does SoftOx Solutions AS do? SoftOx Solutions AS develops infection control solutions for wounds, disinfection, and respiratory care, with products classified as medical devices or medicinal products. The company's portfolio includes SafeDes+, a hand disinfectant designed for irritated, compromised, and eczematous skin. Its business segments are Wounds, Disinfection, and Respiratory, each focusing on specific medical applications. The firm generates revenue through the sale of its products to healthcare providers and medical institutions within these segments. SoftOx Solutions AS operates through subsidiaries such as SoftOx Disinfection AS, SoftOx Defense Solutions AS, and SoftOx Denmark AS, which support the development and distribution of its product range. The company's products are targeted at healthcare facilities requiring specialized infection control solutions, including hospitals and clinics specializing in wound care, respiratory treatments, and disinfection protocols. Revenue is derived from the commercialization of SafeDes+ and other products within its medical device and medicinal product categories. The company's business model centers on research and product development, with a focus on creating solutions for specific medical needs. Its subsidiaries facilitate the operational structure, enabling the company to manage different aspects of product development and market distribution. Sales are driven by the demand for infection control solutions in healthcare settings, particularly for products addressing skin conditions and respiratory health. SoftOx Solutions AS is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing SoftOx Solutions AS's Liabilities

SoftOx Solutions AS's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating SoftOx Solutions AS's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing SoftOx Solutions AS's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

SoftOx Solutions AS's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in SoftOx Solutions AS’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about SoftOx Solutions AS stock

The Liabilities of SoftOx Solutions AS is 10.98 M NOK in 2025.

The Liabilities of SoftOx Solutions AS changed from 25.96 M NOK to 10.98 M NOK, representing a -57.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities SoftOx Solutions AS since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's NOK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's SoftOx Solutions AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — SoftOx Solutions AS

All Key Metrics — SoftOx Solutions AS